Mindfulness Training and Group Counseling Among Prediabetes and Diabetes Patients

January 7, 2021 updated by: Heidi Zinzow, Clemson University

An Innovative Approach With Group Counseling and Mindfulness Training Among Prediabetes Patients

Examining a number of health outcomes in those with diabetes and prediabetes before and after a group-based mindfulness intervention.

Study Overview

Detailed Description

This is a pilot study to examine the feasibility of integrating a mindfulness-based stress reduction (MBSR) intervention in addition to an existing group-based, peer supported clinical care model (JUMP) among patients with pre-diabetes or diabetes using a mixed-method design.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Carolina
      • Greenville, South Carolina, United States, 29605
        • Prisma Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years or older
  • English speaking
  • Having a diagnosis of diabetes or prediabetes
  • Participation in a previous group-based clinical care model-JUMP (as in "JUMPing into Diabetes Control")

Exclusion Criteria:

  • Under 18 years old
  • Non-English Speaking
  • not having a diagnosis of diabetes or prediabetes
  • No participation in JUMP model

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Only Arm
This is a single-arm, paired-sample pilot intervention study among participants with pre-diabetes or diabetes. Goal to integrate a MBSR intervention into a group-based, lifestyle intervention among patients with prediabetes or diabetes in the primary care setting
Mindfulness Based Stress Reduction (MBSR) is a well-documented approach to reduce participants' stress level [19], with the existing group-based peer support, self-empowerment, and lifestyle counseling intervention. MBSR is a type of meditation therapy with the goal of actively cultivating conscious attention and awareness to enhance health benefits. This included 10 hours of intervention with groups of 3-5 people.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention Attendance
Time Frame: 8-weeks while completing the intervention
How many hours of intervention sessions an individual attended
8-weeks while completing the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Stress Scale
Time Frame: Up to 3 months before intervention, immediately following intervention, one month after intervention
Change in perceived stress measured by 4 Items to assess perceived stress where higher levels indicating higher levels of stress with a range of 4 to 20.
Up to 3 months before intervention, immediately following intervention, one month after intervention
Depression
Time Frame: Up to 3 months before intervention, immediately following intervention, one month after intervention
Change in depression scores from the Center for Epidemiologic Studies Depression Scale (CES-D), where higher scores indicate higher levels of depression with a range of 0 to 80.
Up to 3 months before intervention, immediately following intervention, one month after intervention
Anxiety
Time Frame: Up to 3 months before intervention, immediately following intervention, one month after intervention
Change in anxiety assessed using the Generalized anxiety disorder 7-item scale (GAD-7).
Up to 3 months before intervention, immediately following intervention, one month after intervention
Medication Adherence
Time Frame: Up to 3 months before intervention, immediately following intervention, one month after intervention
Change in medication adherence assessed using the 8-item Morisky Medication Adherence Scale. A higher score indicates higher adherence with a range of 0 to 8.
Up to 3 months before intervention, immediately following intervention, one month after intervention
Perceived Health Status
Time Frame: Up to 3 months before intervention, immediately following intervention, one month after intervention
Change in perceived health status assessed using a question asking participants to rate their health status on a 5-points rating scale where lower ratings indicate higher levels of perceived health status and higher ratings indicate lower levels of perceived health status.
Up to 3 months before intervention, immediately following intervention, one month after intervention
Sleep Quality
Time Frame: Up to 3 months before intervention, immediately following intervention, one month after intervention
Change in sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI) ranges from 7 to 28, with higher scores indicating worse sleep quality.
Up to 3 months before intervention, immediately following intervention, one month after intervention
Physical Activity
Time Frame: Up to 3 months before intervention, immediately following intervention, one month after intervention
Change in physical activity assessed using the Rapid Assessment of Physical Activity Scale (RAPA).
Up to 3 months before intervention, immediately following intervention, one month after intervention
Mindfulness
Time Frame: Up to 3 months before intervention, immediately following intervention, one month after intervention
Change in Mindfulness assessed using a 15-item Five-Facet Mindfulness Questionnaire (FFMQ).
Up to 3 months before intervention, immediately following intervention, one month after intervention
HbA1C levels
Time Frame: Up to 3 months before intervention, immediately following intervention, one month after intervention
HbA1C blood levels
Up to 3 months before intervention, immediately following intervention, one month after intervention
Program satisfaction and barriers for attending sessions
Time Frame: Immediately following intervention
Open ended questions to address engagement in the intervention, perceived usefulness of the MBSR, recommendations for intervention modification, what participants enjoyed most/least about the intervention, and reasons for missing intervention sessions. This is a qualitative measure, not numeric values were assigned. Based on Zgierska A, Rabago D, Zuelsdorff M, Coe C, Miller M, Fleming M. Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study. J Addict Med. 2008 Sep;2(3):165-73. doi: 10.1097/ADM.0b013e31816f8546.
Immediately following intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2018

Primary Completion (ACTUAL)

January 31, 2020

Study Completion (ACTUAL)

January 31, 2020

Study Registration Dates

First Submitted

November 23, 2020

First Submitted That Met QC Criteria

January 7, 2021

First Posted (ACTUAL)

January 11, 2021

Study Record Updates

Last Update Posted (ACTUAL)

January 11, 2021

Last Update Submitted That Met QC Criteria

January 7, 2021

Last Verified

December 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Mindfulness Based Stress Reduction

3
Subscribe